Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
  • A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
  • A61F13/0206—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings
  • A61F13/0209—Adhesive bandages or dressings with fluid retention members with absorbent fibrous layers, e.g. woven or non-woven absorbent pads or island dressings comprising superabsorbent material
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
  • A61F13/022—Adhesive bandages or dressings with fluid retention members having more than one layer with different fluid retention characteristics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/02—Adhesive bandages or dressings
  • A61F13/0203—Adhesive bandages or dressings with fluid retention members
  • A61F13/0223—Adhesive bandages or dressings with fluid retention members characterized by parametric properties of the fluid retention layer, e.g. absorbency, wicking capacity, liquid distribution
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
  • A61M1/91—Suction aspects of the dressing
  • A61M1/915—Constructional details of the pressure distribution manifold
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
  • A61M1/96—Suction control thereof
  • A61M1/964—Suction control thereof having venting means on or near the dressing
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
  • A61M1/98—Containers specifically adapted for negative pressure wound therapy
  • A61M1/984—Containers specifically adapted for negative pressure wound therapy portable on the body
  • A61M1/985—Containers specifically adapted for negative pressure wound therapy portable on the body the dressing itself forming the collection container

Definitions

• the present disclosure generally relates to a negative pressure wound therapy (NPWT) dressing. It also relates to a system and to a kit comprising such a dressing.
• NGWT negative pressure wound therapy
• the NPWT technique has, until now, mainly been applied to a patient while in a hospital environment.
• recent product development allows the technique to be used by a patient in a home environment.
• the present disclosure is based on the realization that an appropriate balance between distribution of wound exudate stored by the dressing, and wound exudate removed from the dressing (to the remote fluid collection means) can be achieved. Thereby, the wear time of the dressing is improved.
• the dressing of the present disclosure comprises a tubing configured to connect the dressing to a remotely arranged fluid collection means.
• wound exudate is both stored by and removed from the dressing.
• the dressing is designed to both secure efficient distribution of liquid within the dressing, but to also secure transfer of a substantial amount of liquid away from the dressing by means of the tubing. If the dressing absorbs too fast, and too “much”, the dressing may become saturated before the exudate transfer towards the remote fluid collection means has initiated.
• This range is beneficial to achieve the appropriate balance of liquid absorption vs liquid removal from the dressing.
• a distribution of SAP particles in the above range allows for “sufficient” absorption and retention by the absorbent structure.
• the dressing preferably does not absorb “too much” (or “too quickly”) since this may result in a disturbed balance between the distribution of exudate between the dressing and the canister.
• the absorbent structure is thus configured to optimize the distribution of wound exudate within the dressing, but also to secure removal of exudate towards the remotely arranged fluid collection means.
• the absorbent structure may have a basis weight of from 250 to 550 g/m2, preferably of from 350 to 450 g/m2.
• the absorbent structure is embossed.
• the embossed absorbent structure improves the fluid handling properties of the dressing and contributes to a balanced and more controlled spreading of wound exudate. Furthermore, the embossed absorbent structure allows the dressing to retain its shape and thinness, while also being pliable.
• the liquid spreading layer also improves the distribution of potential “backflow” exudate; i.e. exudate flowing in the opposite direction (from the tubing to the dressing). This may for example occur if the dressing is disconnected from the negative pressure source and/or the remote fluid collection means.
• the liquid spreading layer secures that such back-flow of exudate is spread out rather than flowing back towards the wound site in one spot. This way, the wound site can be kept relatively dry.
• the backing layer and at least a portion of the absorbent structure comprise an opening arranged underneath the coupling member, wherein the liquid spreading layer, if present, is void of an opening.
• the liquid spreading layer is void of such an opening to prevent potential gelling particles and undesired larger particulate of the exudate from entering the tubing of the dressing.
• the liquid spreading layer is configured to transfer liquid from within the dressing through the tubing and to the remote fluid collection means.
• the apertures serve to improve the absorption of wound exudate into the dressing, and are therefore arranged in the area where absorption takes place.
• the area of the absorbent layer forming the border portion of the dressing is preferably void of apertures.
• the backing layer has a moisture vapor transmission rate (MVTR) in the range of from 500 to 3500 g/m2/24h, preferably in the range of from 600 to 2700 g/m2/24h, as measured by NWSP070.4R0(15).
• MVTR moisture vapor transmission rate
• the transmission layer 106 is configured to return to its original shape immediately after removal of the force.
• the dressing comprises a plurality of adhesive stripes 107 between the transmission layer 106 and the absorbent structure 103.
• the liquid spreading layer 108 aids in driving the fluid away from the wound site and from the absorbent structure 103, while at the same time securing that the maximum capacity of the absorbent dressing can be utilized.
• the lack of apertures in the border portion of the dressing is beneficial to improve the adhesion at the border portion 110 of the dressing and thereby improve the stay- on ability of the dressing.
• the adhesive skin contact layer 102 preferably comprises a silicone based adhesive; i.e. a silicone gel.
• a silicone based adhesive i.e. a silicone gel.
• An adhesive skin contact layer comprising a silicone gel is skin- friendly and easy to remove without causing trauma. It is sufficiently adherent to skin such that the dressing stays in place, yet is configured to maintain its adherence with repeated removal and re-application.
• the backing layer 101 is the outermost layer of the dressing and is configured to face away from the skin of a wearer.
• the backing layer has a moisture vapor transmission rate (MVTR) in the range of from 500 to 3500 g/m2/24h, preferably in the range of from 600 to 2700, e.g. from 700 to 2600, such as from 1400 to 2600 g/m2/24h.
• MVTR moisture vapor transmission rate
• the backing layer may 101 comprise at least one film.
• the backing layer may comprise more than one films.
• the backing layer is a laminate formed by two or more films.
• a thin layer of adhesive such as a polyacrylate adhesive, may be applied to the backing layer to attach the backing layer to the adhesive skin contact layer or, where present, an absorbent structure or any other layer of the dressing.
• the backing layer 101 comprises the at least one film comprising a thermoplastic elastomer and an adhesive (e g. polyacrylate) applied thereon.
• the adhesive may be applied in a continuous or discontinuous pattern.
• the coupling member 104 typically comprises an attachment portion configured to be attached to the backing layer of the dressing.
• the coupling member may be adhesively attached to the backing layer.
• the coupling member may also comprise a fluid inlet and a fluid outlet configured to be connected to the tubing 105; i.e. to the air conduit 113, and to the fluid conduit 112, respectively.
• the coupling member may have the construction as defined in EP application No. 13152841 6
• the NPWT system 200 comprises
• the negative pressure source is a negative pressure pump adapted for establishing a negative pressure when the negative pressure pump is in an active state.
• the negative pressure pump may be any type of pump that is biocompatible and maintains or draws adequate and therapeutic vacuum levels.
• the negative pressure level to be achieved is in a range between about -20 rnmlTg and about -300 mmHg.
• a negative pressure range between about -80 mmHg and about -180, preferably between about -100 and - 150 mmHg, more preferably between -110 and -140 mmHg is used.
• the negative pressure pump is a pump of the diaphragmatic or peristaltic type.
• fluidly connected should be interpreted broadly and may comprise e.g. any form of tubing, conduits, or channels providing a fluid connection/communication between the remote fluid collection means 117 and the negative pressure source and the dressing 100.
• the remote fluid collection means 117 may be any kind of fluid container, e.g. a canister. Alternatively, it may be an absorbent material present within the tubing of the NPWT dressing or NPWT system or a dressing or absorbent structure arranged between the dressing of the present disclosure and the canister. Typically, the remote fluid collection means 117 is a canister.
• an inner volume of the canister 117 is between 30 - 300 ml, e g between 40 and 150 ml.
• the inner volume of the canister 103 may vary depending on the type of wound.
• the canister 117 comprises a liquid absorbent material. In a possible embodiment at least 75% of the inner volume of the canister 103 is occupied with a liquid absorbent material.
• the NPWT device 118 may be connected to the dressing 101 by means of the tubing 105.
• the NPWT system comprises a connector unit 119 at a position between the dressing 100 and the NPWT device 118.
• the connector unit 119 may comprise the first connector portion (denoted 114 in figure 1) and the second connector portion (see 123 in figure 3).
• the connector portions 114 and 123 are preferably detachably connected such that the dressing can be easily disconnected from the NPWT device 118. This is beneficial in portable NPWT systems as the user may decide to disconnect the dressing from the device 118 when he/she is going to take a shower or for some other reason.
• the tubing 105 is a double conduit, whereas the tubing 120 between the NPWT device 118 and the connector unit 119 is a single conduit.
• the NPWT system is by no means limited to such a construction, but may comprise a single conduit or a double conduit between the NPWT device 118 and the dressing 100.
• the NPWT system is also not limited to the use of a connector unit 119.
• the tubing 105 may, in embodiments be configured to extend all the way to the NPWT device 118.
• the NPWT system 200 preferably comprises means to supply air to the dressing at a rate of from 2 to 7 ml/min during operation.
• the means to supply air to the dressing is configured to supply air at a rate of from 2-7 ml, preferably of from 3-5 ml at a negative pressure of from -80 to -180 mmHg, preferably of from -100 to -150 mmHg, more preferably of from -110 to -140 mmHg.
• the first and/or the second connector portion (114 and 123) may comprise an air filter (not shown) configured to control the supply of air into the dressing 100 and/or into the tubing 105.
• the first and/or the second connector portion (114 and 123) may e.g. comprise an air inlet port, wherein the air filter is arranged.
• the air filter preferably comprises a hydrophobic and porous material, wherein the size of the pores is within the range of from 2 to 20 pm, preferably in the range of from 5 to 12 pm.
• the pore size of the filter is measured in a non-compressed state.
• the air filter preferably comprises polyethylene, preferably sintered polyethylene.
• the air filter secures that the supply of air is in the range of from 2-7 ml/min during operation, e.g. at a negative pressure of - 80 mmHg to -150 mm Hg, e.g. from -100 mmHg to -130 mmHg.
• air may be introduced into the system in alternative ways, and an air filter may be provided at alternative positions in the system.
• the regulation of air supply may, in embodiments, be controlled by the NPWT device 118.
• the dressing 100 is arranged at a wound site of the user/patient, forming a sealed space.
• the tubing (105 and 120) is provided to fluidly connect the dressing 100 to the NPWT device 118, e.g. to an inlet port of the NPWT device 118.
• the NPWT device 118 is then activated, e.g. by the user/patient, by pressing the start/pause button 122.
• the negative pressure pump is thereby activated. When activated, the negative pressure pump will start to evacuate air through the canister 117, the tubing (120 and 105) and the sealed space formed by the dressing 100. Accordingly, the negative pressure will be created within the sealed space.
• this liquid from the wound site may at least partly be “drawn” from the wound site, through the tubing (105 and 120), and into the canister 117.
• the amount of liquid; i.e. exudate that is drawn from the wound and collected in the canister 117 will depend on the type of wound that is being treated as well as the type of wound dressing used. Within the context of the present disclosure, a substantially equal balance between liquid distribution is desired.
• a suitable filter member (not shown) may be arranged between the canister 117 and the negative pressure pump to ensure that no liquid is allowed to pass to the negative pressure pump from the canister 117.
• the canister 117 may comprise an inlet port for allowing connection to the tubing 120.
• the connection between the inlet port and the tubing 120 is preferably a sealed connection, thus ensuring that no leakage is formed at the inlet port during normal operation of the NPWT device 118.
• the tubing 120 is preferably releasably connected to the inlet port through conventional means including a friction fit, bayonet coupling, snap fit, barbed connector, or the like. A similar sealed is formed between the canister 117 and the negative pressure pump.
• Figure 3 illustrates a kit 300 according to an exemplary embodiment.
• the kit 300 comprises at least one NPWT dressing 100 as described hereinbefore.
• the dressing comprises a tubing 105.
• the tubing 105 is pre-attached to the dressing, e . by means of a coupling member 104 attached to the backing layer of the dressing 100.
• the fact that the tubing 105 is pre-attached allows for a quick assembly of the components of the system/kit.
• the distal end of the tubing 105 is connected to a first connector portion 114.
• the kit may further comprise a negative pressure source arranged within a housing 116.
• the kit may also comprise a canister 117.
• the canister may comprise a second tubing 120.
• the distal end of the second tubing 120 may comprise a second connector portion 123.
• the second connector portion 123 is configured to be connected to the first connector portion 114 associated with the tubing 105 of the dressing 100.
• the kit 300 may comprise additional components such as additional batteries 124 for powering the NPWT device 118 and adhesive strips 125 for improving the adhesion between the border portion of the dressing to the skin of a wearer.
• the kit 300 may comprise a plurality of NPWT dressings as described herein before, optionally packaged together with a plurality of adhesive stripes.
• Pre-weighed dressings were attached to a plexiglass plate of a larger size than the dressing area.
• the plexiglass plate had a hole for liquid inflow.
• the dressings were positioned so that the liquid inflow was in the middle portion of the dressing.
• Each dressing comprised a tubing that was connected to a mobile negative pressure device as illustrated in figure 2.
• the pump used was a pump of diaphragmatic type.
• a canister configured to store 50 ml of liquid was used and was connected to the pump arranged within a housing as disclosed in figure 2.
• the dressing and the NPWT device (comprising the canister and the pump) were connected by respective connector portions, as described hereinbefore.
• An air filter was arranged within the first connector portion associated with the dressing tubing. Ambient air was introduced into the connector and into the system such that the supply of air to the dressing was within the range of 2-7 ml/min.
• the pump was activated, and a negative pressure of - 125 mmHg was applied

Landscapes

• Health & Medical Sciences (AREA)
• Heart & Thoracic Surgery (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Vascular Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Anesthesiology (AREA)
• Hematology (AREA)
• Media Introduction/Drainage Providing Device (AREA)
• Materials For Medical Uses (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)

Priority Applications (8)

Applications Claiming Priority (2)

Publications (1)

Family

ID=70804576

Family Applications (1)

Country Status (11)

Cited By (3)

Families Citing this family (3)

Citations (2)

Family Cites Families (66)

• 2020
  • 2020-05-25 DK DK20176277.0T patent/DK3915531T3/da active
  • 2020-05-25 EP EP20176277.0A patent/EP3915531B1/en active Active
  • 2020-05-25 ES ES20176277T patent/ES2984023T3/es active Active
• 2021
  • 2021-05-24 US US17/999,229 patent/US12447258B2/en active Active
  • 2021-05-24 JP JP2022570711A patent/JP2023526486A/ja active Pending
  • 2021-05-24 BR BR112022023293A patent/BR112022023293A2/pt unknown
  • 2021-05-24 WO PCT/EP2021/063748 patent/WO2021239653A1/en not_active Ceased
  • 2021-05-24 AU AU2021279130A patent/AU2021279130A1/en active Pending
  • 2021-05-24 EP EP21727167.5A patent/EP4157175B1/en active Active
  • 2021-05-24 CA CA3177150A patent/CA3177150A1/en active Pending
  • 2021-05-24 KR KR1020227039918A patent/KR20230016628A/ko active Pending
  • 2021-05-24 CN CN202180036351.6A patent/CN115666469A/zh active Pending

Patent Citations (2)

Also Published As

Similar Documents

Legal Events